Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Continuous Intra-femoral Urokinase for Diabetic Foot Ulcers
NCT01108120Phase 2Completed
- Start
- May 2010
- Primary completion
- Dec 2022
- Modality
- Therapeutic Enzymes
- Countries
- 1
01
Overview
Phase 2, randomised, open-label trial of urokinase in diabetic foot ulcer (DFU) (2 arms). Primary endpoints: healing rate of diabetic foot ulcers and The recurrence rate of diabetic foot ulcers at 8 years. Started May 2010; status: completed.
02
Drugs
urokinase
03
Conditions
diabetic foot ulcer (DFU)
Beyond the preview
Go deeper on NCT01108120.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01108120.